GEIST:UPC Searchengine

UPC_CFI_14/2023

Amgen Inc. v. Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., Regeneron Pharmaceuticals Inc.

Datum
2024-01-02
Kammer
Munich (DE) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_14-2023-dd343e97ddfd
Aktenzeichen
RegisterzeichenUPC_CFI_14/2023
EntscheidungsreferenzORD_597730/2023
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

1 Local Division Munich UPC_CFI_14/2023 ACT_ 459916/2023 CC_586764/2023 ORD_597730/2023 Order in the action before the Court of First Instance of the Unified Patent Court concerning European Patent 3 666 797 delivered on 02/01/2024 Date of receipt of Statement of claim : 01/06/2023 CLAIMANT/S 1) Amgen Inc. One Amgen Center Drive, Mail-Stop 28-2-C - 91320-1799 - Thousand Oaks - US Represented by Johannes Heselberger DEFENDANT/S 1) Sanofi-Aventis Deutschland GmbH Industriepark Höchst, Brüningstraße 50 - 65926 - Frankfurt am Main - DE Represented by Niels Hölder 2) Sanofi-Aventis Groupe S.A. 54 rue La BoØtie - 75008 - Paris - FR Represented by Niels Hölder 2 3) Sanofi Winthrop Industrie S.A. 82 avenue Raspail - 94250 - Gentilly - FR Represented by Niels Hölder 4) Regeneron Pharmaceuticals Inc ...